Company profile
St. Joseph, Inc.
OTC: STJO · Healthcare · Medical - Devices
#829 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
67BFH 83DQ —GM 34SS 36
v0.1 · 45/100 weight · provisional
↑ balance-sheet leverage, Piotroski F · ↓ workforce scale, growth stability
Methodology →Revenue TTM
$1.8M
Rev growth YoY (TTM)
-23.1%
Net income (FY)
-$14.4k
Employees
1
as of 2026-08-25
Market cap
$1.1M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.5M$1.5M2025
Net income-$14.4k-$14.4k2025
Operating income-$6.5k-$6.5k2025
Total assets$7.1M$7.1M2025
Liabilities$189.9k$189.9k2025
Equity$6.9M$6.9M2025
Revenue trend
FY2013 – FY2025 · USD
FY13
FY14
FY15
FY19
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is St. Joseph, Inc.’s revenue?
St. Joseph, Inc. booked $1.5M in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -0.9% net margin.
Peers · Healthcare
Orthometrix, Inc.——Molecule Holdings Inc.——New Leaf Ventures Inc——Statera Biopharma, Inc.——Xsovt Brands, Inc.——Glow Lifetech Corp.——Neighbors
Collin →Key facts
CEOGerald R. McIlhargey
SectorHealthcare
IndustryMedical - Devices
HeadquartersMcKinney, TX
ExchangeOTC: STJO
Employees1
IPO date2005-08-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.